Other
Equity method investments (Note 11)
Medtronic Equity method investments (Note 11) decreased by 4.8% to $79.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $77.00M to $79.00M.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Growth in this metric indicates strategic expansion through partnerships, while a decline may reflect divestitures or impairment of joint venture performance.
Detailed definition
This represents the company's interest in entities where it exerts significant influence but does not have full control,...
Peer comparison
Common for large-scale infrastructure companies that utilize joint ventures to manage complex logistics networks.
Metric ID:
other_equity_method_investmentsHistorical Data
6 periods
| Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $84.00M | $77.00M | $89.00M | $83.00M | $83.00M | $79.00M |
| QoQ Change | — | -8.3% | +15.6% | -6.7% | +0.0% | -4.8% |
| YoY Change | — | — | +6.0% | — | — | +2.6% |
Range$77.00M – $89.00M
CAGR-4.8%
Avg YoY Growth+4.3%
Median YoY Growth+4.3%
Equity method investments (Note 11) at Other Companies
Frequently Asked Questions
- What is Medtronic's equity method investments (note 11)?
- Medtronic (MDT) reported equity method investments (note 11) of $79.00M in Q4 2025.
- How has Medtronic's equity method investments (note 11) changed year-over-year?
- Medtronic's equity method investments (note 11) increased by 2.6% year-over-year, from $77.00M to $79.00M.
- What does equity method investments (note 11) mean?
- The value of the company's ownership stakes in other businesses where it has significant influence but not full control.